Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia
Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathol...
Saved in:
| Published in | Acta neuropathologica communications Vol. 7; no. 1; pp. 4 - 14 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
07.01.2019
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathologies rather than changes in the neurosensory retina or the optic nerve. Here, we examined tau pathology in the neurosensory retina of the rTg(tauP301L)4510 mouse model of FTD. Optic nerve pathology in mice was also assessed using MRI, and corresponding measurements taken in a cohort of five FTD sufferers and five healthy controls. rTg(tauP301L)4510 mice were imaged (T2-weighted MRI) prior to being terminally anesthetized and eyes and brains removed for immunohistochemical and histological analysis. Central and peripheral retinal labelling of tau and phosphorylated tau (pTau) was quantified and retinal layer thicknesses and cell numbers assessed. MR volumetric changes of specific brain regions and the optic nerve were compared to tau accumulation and cell loss in the visual pathway. In addition, the optic nerves of a cohort of healthy controls and behavioural variant FTD patients, were segmented from T1- and T2-weighted images for volumetric study. Accumulation of tau and pTau were observed in both the central and peripheral retinal ganglion cell (RGC), inner plexiform and inner nuclear layers of the neurosensory retina of rTg(tauP301L)4510 mice. This pathology was associated with reduced nuclear density (- 24.9 ± 3.4%) of the central RGC layer, and a reduced volume (- 19.3 ± 4.6%) and elevated T2 signal (+ 27.1 ± 1.8%) in the optic nerve of the transgenic mice. Significant atrophy of the cortex (containing the visual cortex) was observed but not in other area associated with visual processing, e.g. the lateral geniculate nucleus or superior colliculus. Atrophic changes in optic nerve volume were similarly observed in FTD patients (- 36.6 ± 2.6%). The association between tau-induced changes in the neurosensory retina and reduced optic nerve volume in mice, combined with the observation of optic nerve atrophy in clinical FTD suggests that ophthalmic tau pathology may also exist in the eyes of FTD patients. If tau pathology and neurodegeneration in the retina were to reflect the degree of cortical tau burden, then cost-effective and non-invasive imaging of the neurosensory retina could provide valuable biomarkers in tauopathy. Further work should aim to validate whether these observations are fully translatable to a clinical scenario, which would recommend follow-up retinal and optic nerve examination in FTD. |
|---|---|
| AbstractList | Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathologies rather than changes in the neurosensory retina or the optic nerve. Here, we examined tau pathology in the neurosensory retina of the rTg(tauP301L)4510 mouse model of FTD. Optic nerve pathology in mice was also assessed using MRI, and corresponding measurements taken in a cohort of five FTD sufferers and five healthy controls. rTg(tauP301L)4510 mice were imaged (T2-weighted MRI) prior to being terminally anesthetized and eyes and brains removed for immunohistochemical and histological analysis. Central and peripheral retinal labelling of tau and phosphorylated tau (pTau) was quantified and retinal layer thicknesses and cell numbers assessed. MR volumetric changes of specific brain regions and the optic nerve were compared to tau accumulation and cell loss in the visual pathway. In addition, the optic nerves of a cohort of healthy controls and behavioural variant FTD patients, were segmented from T1- and T2-weighted images for volumetric study. Accumulation of tau and pTau were observed in both the central and peripheral retinal ganglion cell (RGC), inner plexiform and inner nuclear layers of the neurosensory retina of rTg(tauP301L)4510 mice. This pathology was associated with reduced nuclear density (- 24.9 [+ or -] 3.4%) of the central RGC layer, and a reduced volume (- 19.3 [+ or -] 4.6%) and elevated T2 signal (+ 27.1 [+ or -] 1.8%) in the optic nerve of the transgenic mice. Significant atrophy of the cortex (containing the visual cortex) was observed but not in other area associated with visual processing, e.g. the lateral geniculate nucleus or superior colliculus. Atrophic changes in optic nerve volume were similarly observed in FTD patients (- 36.6 [+ or -] 2.6%). The association between tau-induced changes in the neurosensory retina and reduced optic nerve volume in mice, combined with the observation of optic nerve atrophy in clinical FTD suggests that ophthalmic tau pathology may also exist in the eyes of FTD patients. If tau pathology and neurodegeneration in the retina were to reflect the degree of cortical tau burden, then cost-effective and non-invasive imaging of the neurosensory retina could provide valuable biomarkers in tauopathy. Further work should aim to validate whether these observations are fully translatable to a clinical scenario, which would recommend follow-up retinal and optic nerve examination in FTD. Keywords: Tau, Frontotemporal dementia, Neurosensory retina, MRI Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathologies rather than changes in the neurosensory retina or the optic nerve. Here, we examined tau pathology in the neurosensory retina of the rTg(tauP301L)4510 mouse model of FTD. Optic nerve pathology in mice was also assessed using MRI, and corresponding measurements taken in a cohort of five FTD sufferers and five healthy controls. rTg(tauP301L)4510 mice were imaged (T2-weighted MRI) prior to being terminally anesthetized and eyes and brains removed for immunohistochemical and histological analysis. Central and peripheral retinal labelling of tau and phosphorylated tau (pTau) was quantified and retinal layer thicknesses and cell numbers assessed. MR volumetric changes of specific brain regions and the optic nerve were compared to tau accumulation and cell loss in the visual pathway. In addition, the optic nerves of a cohort of healthy controls and behavioural variant FTD patients, were segmented from T1- and T2-weighted images for volumetric study. Accumulation of tau and pTau were observed in both the central and peripheral retinal ganglion cell (RGC), inner plexiform and inner nuclear layers of the neurosensory retina of rTg(tauP301L)4510 mice. This pathology was associated with reduced nuclear density (− 24.9 ± 3.4%) of the central RGC layer, and a reduced volume (− 19.3 ± 4.6%) and elevated T2 signal (+ 27.1 ± 1.8%) in the optic nerve of the transgenic mice. Significant atrophy of the cortex (containing the visual cortex) was observed but not in other area associated with visual processing, e.g. the lateral geniculate nucleus or superior colliculus. Atrophic changes in optic nerve volume were similarly observed in FTD patients (− 36.6 ± 2.6%). The association between tau-induced changes in the neurosensory retina and reduced optic nerve volume in mice, combined with the observation of optic nerve atrophy in clinical FTD suggests that ophthalmic tau pathology may also exist in the eyes of FTD patients. If tau pathology and neurodegeneration in the retina were to reflect the degree of cortical tau burden, then cost-effective and non-invasive imaging of the neurosensory retina could provide valuable biomarkers in tauopathy. Further work should aim to validate whether these observations are fully translatable to a clinical scenario, which would recommend follow-up retinal and optic nerve examination in FTD. Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathologies rather than changes in the neurosensory retina or the optic nerve. Here, we examined tau pathology in the neurosensory retina of the rTg(tauP301L)4510 mouse model of FTD. Optic nerve pathology in mice was also assessed using MRI, and corresponding measurements taken in a cohort of five FTD sufferers and five healthy controls. rTg(tauP301L)4510 mice were imaged (T2-weighted MRI) prior to being terminally anesthetized and eyes and brains removed for immunohistochemical and histological analysis. Central and peripheral retinal labelling of tau and phosphorylated tau (pTau) was quantified and retinal layer thicknesses and cell numbers assessed. MR volumetric changes of specific brain regions and the optic nerve were compared to tau accumulation and cell loss in the visual pathway. In addition, the optic nerves of a cohort of healthy controls and behavioural variant FTD patients, were segmented from T1- and T2-weighted images for volumetric study. Accumulation of tau and pTau were observed in both the central and peripheral retinal ganglion cell (RGC), inner plexiform and inner nuclear layers of the neurosensory retina of rTg(tauP301L)4510 mice. This pathology was associated with reduced nuclear density (- 24.9 ± 3.4%) of the central RGC layer, and a reduced volume (- 19.3 ± 4.6%) and elevated T2 signal (+ 27.1 ± 1.8%) in the optic nerve of the transgenic mice. Significant atrophy of the cortex (containing the visual cortex) was observed but not in other area associated with visual processing, e.g. the lateral geniculate nucleus or superior colliculus. Atrophic changes in optic nerve volume were similarly observed in FTD patients (- 36.6 ± 2.6%). The association between tau-induced changes in the neurosensory retina and reduced optic nerve volume in mice, combined with the observation of optic nerve atrophy in clinical FTD suggests that ophthalmic tau pathology may also exist in the eyes of FTD patients. If tau pathology and neurodegeneration in the retina were to reflect the degree of cortical tau burden, then cost-effective and non-invasive imaging of the neurosensory retina could provide valuable biomarkers in tauopathy. Further work should aim to validate whether these observations are fully translatable to a clinical scenario, which would recommend follow-up retinal and optic nerve examination in FTD. Abstract Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathologies rather than changes in the neurosensory retina or the optic nerve. Here, we examined tau pathology in the neurosensory retina of the rTg(tauP301L)4510 mouse model of FTD. Optic nerve pathology in mice was also assessed using MRI, and corresponding measurements taken in a cohort of five FTD sufferers and five healthy controls. rTg(tauP301L)4510 mice were imaged (T2-weighted MRI) prior to being terminally anesthetized and eyes and brains removed for immunohistochemical and histological analysis. Central and peripheral retinal labelling of tau and phosphorylated tau (pTau) was quantified and retinal layer thicknesses and cell numbers assessed. MR volumetric changes of specific brain regions and the optic nerve were compared to tau accumulation and cell loss in the visual pathway. In addition, the optic nerves of a cohort of healthy controls and behavioural variant FTD patients, were segmented from T1- and T2-weighted images for volumetric study. Accumulation of tau and pTau were observed in both the central and peripheral retinal ganglion cell (RGC), inner plexiform and inner nuclear layers of the neurosensory retina of rTg(tauP301L)4510 mice. This pathology was associated with reduced nuclear density (− 24.9 ± 3.4%) of the central RGC layer, and a reduced volume (− 19.3 ± 4.6%) and elevated T2 signal (+ 27.1 ± 1.8%) in the optic nerve of the transgenic mice. Significant atrophy of the cortex (containing the visual cortex) was observed but not in other area associated with visual processing, e.g. the lateral geniculate nucleus or superior colliculus. Atrophic changes in optic nerve volume were similarly observed in FTD patients (− 36.6 ± 2.6%). The association between tau-induced changes in the neurosensory retina and reduced optic nerve volume in mice, combined with the observation of optic nerve atrophy in clinical FTD suggests that ophthalmic tau pathology may also exist in the eyes of FTD patients. If tau pathology and neurodegeneration in the retina were to reflect the degree of cortical tau burden, then cost-effective and non-invasive imaging of the neurosensory retina could provide valuable biomarkers in tauopathy. Further work should aim to validate whether these observations are fully translatable to a clinical scenario, which would recommend follow-up retinal and optic nerve examination in FTD. Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathologies rather than changes in the neurosensory retina or the optic nerve. Here, we examined tau pathology in the neurosensory retina of the rTg(tauP301L)4510 mouse model of FTD. Optic nerve pathology in mice was also assessed using MRI, and corresponding measurements taken in a cohort of five FTD sufferers and five healthy controls. rTg(tauP301L)4510 mice were imaged (T2-weighted MRI) prior to being terminally anesthetized and eyes and brains removed for immunohistochemical and histological analysis. Central and peripheral retinal labelling of tau and phosphorylated tau (pTau) was quantified and retinal layer thicknesses and cell numbers assessed. MR volumetric changes of specific brain regions and the optic nerve were compared to tau accumulation and cell loss in the visual pathway. In addition, the optic nerves of a cohort of healthy controls and behavioural variant FTD patients, were segmented from T1- and T2-weighted images for volumetric study. Accumulation of tau and pTau were observed in both the central and peripheral retinal ganglion cell (RGC), inner plexiform and inner nuclear layers of the neurosensory retina of rTg(tauP301L)4510 mice. This pathology was associated with reduced nuclear density (- 24.9 [+ or -] 3.4%) of the central RGC layer, and a reduced volume (- 19.3 [+ or -] 4.6%) and elevated T2 signal (+ 27.1 [+ or -] 1.8%) in the optic nerve of the transgenic mice. Significant atrophy of the cortex (containing the visual cortex) was observed but not in other area associated with visual processing, e.g. the lateral geniculate nucleus or superior colliculus. Atrophic changes in optic nerve volume were similarly observed in FTD patients (- 36.6 [+ or -] 2.6%). The association between tau-induced changes in the neurosensory retina and reduced optic nerve volume in mice, combined with the observation of optic nerve atrophy in clinical FTD suggests that ophthalmic tau pathology may also exist in the eyes of FTD patients. If tau pathology and neurodegeneration in the retina were to reflect the degree of cortical tau burden, then cost-effective and non-invasive imaging of the neurosensory retina could provide valuable biomarkers in tauopathy. Further work should aim to validate whether these observations are fully translatable to a clinical scenario, which would recommend follow-up retinal and optic nerve examination in FTD. Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathologies rather than changes in the neurosensory retina or the optic nerve. Here, we examined tau pathology in the neurosensory retina of the rTg(tauP301L)4510 mouse model of FTD. Optic nerve pathology in mice was also assessed using MRI, and corresponding measurements taken in a cohort of five FTD sufferers and five healthy controls. rTg(tauP301L)4510 mice were imaged (T2-weighted MRI) prior to being terminally anesthetized and eyes and brains removed for immunohistochemical and histological analysis. Central and peripheral retinal labelling of tau and phosphorylated tau (pTau) was quantified and retinal layer thicknesses and cell numbers assessed. MR volumetric changes of specific brain regions and the optic nerve were compared to tau accumulation and cell loss in the visual pathway. In addition, the optic nerves of a cohort of healthy controls and behavioural variant FTD patients, were segmented from T1- and T2-weighted images for volumetric study. Accumulation of tau and pTau were observed in both the central and peripheral retinal ganglion cell (RGC), inner plexiform and inner nuclear layers of the neurosensory retina of rTg(tauP301L)4510 mice. This pathology was associated with reduced nuclear density (- 24.9 ± 3.4%) of the central RGC layer, and a reduced volume (- 19.3 ± 4.6%) and elevated T2 signal (+ 27.1 ± 1.8%) in the optic nerve of the transgenic mice. Significant atrophy of the cortex (containing the visual cortex) was observed but not in other area associated with visual processing, e.g. the lateral geniculate nucleus or superior colliculus. Atrophic changes in optic nerve volume were similarly observed in FTD patients (- 36.6 ± 2.6%). The association between tau-induced changes in the neurosensory retina and reduced optic nerve volume in mice, combined with the observation of optic nerve atrophy in clinical FTD suggests that ophthalmic tau pathology may also exist in the eyes of FTD patients. If tau pathology and neurodegeneration in the retina were to reflect the degree of cortical tau burden, then cost-effective and non-invasive imaging of the neurosensory retina could provide valuable biomarkers in tauopathy. Further work should aim to validate whether these observations are fully translatable to a clinical scenario, which would recommend follow-up retinal and optic nerve examination in FTD.Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been reported in tauopathy disorders, such as frontotemporal dementia (FTD). These impairments however have been previously attributed to cortical pathologies rather than changes in the neurosensory retina or the optic nerve. Here, we examined tau pathology in the neurosensory retina of the rTg(tauP301L)4510 mouse model of FTD. Optic nerve pathology in mice was also assessed using MRI, and corresponding measurements taken in a cohort of five FTD sufferers and five healthy controls. rTg(tauP301L)4510 mice were imaged (T2-weighted MRI) prior to being terminally anesthetized and eyes and brains removed for immunohistochemical and histological analysis. Central and peripheral retinal labelling of tau and phosphorylated tau (pTau) was quantified and retinal layer thicknesses and cell numbers assessed. MR volumetric changes of specific brain regions and the optic nerve were compared to tau accumulation and cell loss in the visual pathway. In addition, the optic nerves of a cohort of healthy controls and behavioural variant FTD patients, were segmented from T1- and T2-weighted images for volumetric study. Accumulation of tau and pTau were observed in both the central and peripheral retinal ganglion cell (RGC), inner plexiform and inner nuclear layers of the neurosensory retina of rTg(tauP301L)4510 mice. This pathology was associated with reduced nuclear density (- 24.9 ± 3.4%) of the central RGC layer, and a reduced volume (- 19.3 ± 4.6%) and elevated T2 signal (+ 27.1 ± 1.8%) in the optic nerve of the transgenic mice. Significant atrophy of the cortex (containing the visual cortex) was observed but not in other area associated with visual processing, e.g. the lateral geniculate nucleus or superior colliculus. Atrophic changes in optic nerve volume were similarly observed in FTD patients (- 36.6 ± 2.6%). The association between tau-induced changes in the neurosensory retina and reduced optic nerve volume in mice, combined with the observation of optic nerve atrophy in clinical FTD suggests that ophthalmic tau pathology may also exist in the eyes of FTD patients. If tau pathology and neurodegeneration in the retina were to reflect the degree of cortical tau burden, then cost-effective and non-invasive imaging of the neurosensory retina could provide valuable biomarkers in tauopathy. Further work should aim to validate whether these observations are fully translatable to a clinical scenario, which would recommend follow-up retinal and optic nerve examination in FTD. |
| ArticleNumber | 4 |
| Audience | Academic |
| Author | Lengyel, Imre O’Callaghan, James M. Bocchetta, Martina Rohrer, Jonathan D. Lythgoe, Mark F. Whitaker, Rozalind Ma, Da Csincsik, Lajos Murray, Tracey K. Fisher, Alice Bertelli, Pietro Maria Harrison, Ian F. Ahmed, Zeshan O’Neill, Michael J. |
| Author_xml | – sequence: 1 givenname: Ian F. orcidid: 0000-0003-1250-4911 surname: Harrison fullname: Harrison, Ian F. – sequence: 2 givenname: Rozalind surname: Whitaker fullname: Whitaker, Rozalind – sequence: 3 givenname: Pietro Maria surname: Bertelli fullname: Bertelli, Pietro Maria – sequence: 4 givenname: James M. surname: O’Callaghan fullname: O’Callaghan, James M. – sequence: 5 givenname: Lajos surname: Csincsik fullname: Csincsik, Lajos – sequence: 6 givenname: Martina surname: Bocchetta fullname: Bocchetta, Martina – sequence: 7 givenname: Da surname: Ma fullname: Ma, Da – sequence: 8 givenname: Alice surname: Fisher fullname: Fisher, Alice – sequence: 9 givenname: Zeshan surname: Ahmed fullname: Ahmed, Zeshan – sequence: 10 givenname: Tracey K. surname: Murray fullname: Murray, Tracey K. – sequence: 11 givenname: Michael J. surname: O’Neill fullname: O’Neill, Michael J. – sequence: 12 givenname: Jonathan D. surname: Rohrer fullname: Rohrer, Jonathan D. – sequence: 13 givenname: Mark F. surname: Lythgoe fullname: Lythgoe, Mark F. – sequence: 14 givenname: Imre surname: Lengyel fullname: Lengyel, Imre |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30616676$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kktr3DAUhU1JadI0P6CbYiiUbiaVrIflTSGEPgKBbNK1kKVrj4ItTSU7kH-f65mknQmtjWUjfedY9-q8LY5CDFAU7yk5p1TJL5kTXqsVofhIwVfyVXFSEUFXopHkaO_7uDjL-Y7g1VDKlHpTHDMiqZS1PCk2N5vJ2zJAuodyWvsQfOhLExxOzSlmCDmmhzLB5IMZSgc9IGsmH0PpAyqgTLc9F5SUY5wz4OhgKGNXdimGKU4wbmLaKkcIkzfvitedGTKcPb1Pi1_fv91e_lxd3_y4ury4XlnR0GnVAmOOiZa3Tcscp0IQ2_BadIRbBS10VWUYdEpwRxgRjAKvpem6lrimsWDYaXG183XR3OlN8qNJDzoar7cTMfXaJCx9AF1RUBYH61jNZdM0qmodB9sS46zben3deW3mdgRnsRAs6cD0cCX4te7jvZasqqqGo8HnJ4MUf8-QJz36bGEYTADsGu5ACiJUJRf04wv0Ls4Je7-lFOeiItVfqjdYgA9dxP_axVRfCKlqrmqhkDr_B4U3Hoa3GKfO4_yB4NOeYA1mmNY5DvNy3PkQ_LDfkT-teA4WAvUOsBiinKDT1k_b2OAW_KAp0UuK9S7FGlOslxTrRUlfKJ_N_695BE1w884 |
| CitedBy_id | crossref_primary_10_1186_s40478_019_0780_9 crossref_primary_10_3390_ijms25031689 crossref_primary_10_3389_fnins_2020_00921 crossref_primary_10_1016_j_nbd_2021_105277 crossref_primary_10_1186_s12974_020_01803_7 crossref_primary_10_3233_JAD_220964 crossref_primary_10_1038_s42003_022_03012_9 crossref_primary_10_1186_s40478_022_01489_3 crossref_primary_10_1523_JNEUROSCI_2148_23_2024 crossref_primary_10_1016_j_phrs_2021_106003 crossref_primary_10_1080_08164622_2021_1984179 crossref_primary_10_1016_j_neuroimage_2020_117271 crossref_primary_10_33619_2414_2948_49_14 |
| Cites_doi | 10.1523/JNEUROSCI.3986-15.2016 10.1159/000487053 10.1007/s10384-004-0156-x 10.3389/neuro.05.001.2008 10.1002/ana.410290110 10.1212/WNL.0000000000004500 10.1093/brain/awr179 10.1016/S0896-6273(00)80615-7 10.1136/bmj.f4827 10.1523/JNEUROSCI.0774-15.2016 10.1016/j.neuroimage.2015.02.023 10.1016/j.lfs.2014.12.019 10.1097/00006324-199502000-00007 10.1111/j.1442-9071.2010.02452.x 10.1016/j.febslet.2008.02.025 10.1016/j.neuroimage.2017.08.003 10.1093/geront/35.3.370 10.1016/j.cmpb.2009.09.002 10.1016/j.neurobiolaging.2009.03.002 10.1016/j.neurobiolaging.2013.12.009 10.1002/cne.21487 10.1155/JBB/2006/74539 10.1097/NEN.0b013e31820376cc 10.1126/science.1113694 10.1093/brain/awr198 10.1136/jnnp.2010.212225 10.1007/s00415-015-7885-2 10.1111/j.1460-9568.2008.06318.x 10.1016/S0733-8619(02)00107-X 10.1002/cne.20368 10.2466/pms.1996.83.3.987 10.1016/S0165-0270(96)00148-3 10.1016/j.preteyeres.2011.11.002 10.1007/s00401-014-1254-6 10.1002/ana.20203 10.1002/humu.20086 10.1002/mrm.21850 10.1371/journal.pone.0096568 10.1167/iovs.10-5921 10.1016/j.neuroimage.2006.01.015 10.1371/journal.pone.0086576 10.1371/journal.pone.0034891 10.3129/i07-185 10.3233/JAD-160886 10.1016/j.media.2013.02.006 10.1007/978-3-540-40899-4_57 10.1016/0006-8993(94)91928-3 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2019 BioMed Central Ltd. Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2019 |
| Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2019 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s40478-018-0654-6 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2051-5960 |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_21e8c21ecd374699982bd4ecb0adcdea PMC6322294 A568748758 30616676 10_1186_s40478_018_0654_6 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Biotechnology and Biological Sciences Research Council grantid: BB/E528979/1 – fundername: Medical Research Council grantid: MR/K026739/1 – fundername: NIHR Rare Disease Translational Research Collaboration grantid: BRC149/NS/MH – fundername: Engineering and Physical Sciences Research Council grantid: EP/N034864/1 – fundername: Medical Research Council grantid: MR/M008525/1 – fundername: Medical Research Council grantid: MR/J500422/1 – fundername: ; – fundername: ; grantid: MR/J500422/1; MR/M008525/1 – fundername: ; grantid: EP/N034864/1 – fundername: ; grantid: BRC149/NS/MH |
| GroupedDBID | 0R~ 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACIHN ACMJI ACUHS ADBBV ADRAZ ADUKV AEAQA AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ASPBG AVWKF BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION DIK EBLON EBS EJD FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 M~E OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SOJ TUS UKHRP CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c591t-be33d35b4b9b3d41550c9475f04c8ebef22a3ef854d030531e476affb0d99cea3 |
| IEDL.DBID | M48 |
| ISSN | 2051-5960 |
| IngestDate | Wed Aug 27 01:31:17 EDT 2025 Thu Aug 21 14:01:49 EDT 2025 Thu Jul 10 19:33:35 EDT 2025 Fri Jul 25 06:36:27 EDT 2025 Tue Jun 17 21:39:18 EDT 2025 Tue Jun 10 20:43:43 EDT 2025 Thu May 22 21:01:09 EDT 2025 Thu Apr 03 06:57:46 EDT 2025 Tue Jul 01 02:28:23 EDT 2025 Thu Apr 24 23:11:33 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Tau Frontotemporal dementia Neurosensory retina MRI |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c591t-be33d35b4b9b3d41550c9475f04c8ebef22a3ef854d030531e476affb0d99cea3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-1250-4911 |
| OpenAccessLink | https://www.proquest.com/docview/2168445202?pq-origsite=%requestingapplication% |
| PMID | 30616676 |
| PQID | 2168445202 |
| PQPubID | 2040178 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_21e8c21ecd374699982bd4ecb0adcdea pubmedcentral_primary_oai_pubmedcentral_nih_gov_6322294 proquest_miscellaneous_2165058264 proquest_journals_2168445202 gale_infotracmisc_A568748758 gale_infotracacademiconefile_A568748758 gale_healthsolutions_A568748758 pubmed_primary_30616676 crossref_citationtrail_10_1186_s40478_018_0654_6 crossref_primary_10_1186_s40478_018_0654_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-01-07 |
| PublicationDateYYYYMMDD | 2019-01-07 |
| PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-07 day: 07 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Acta neuropathologica communications |
| PublicationTitleAlternate | Acta Neuropathol Commun |
| PublicationYear | 2019 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | M Goedert (654_CR16) 1998; 21 K SantaCruz (654_CR43) 2005; 309 L Ferrari (654_CR13) 2017; 56 Z Ahmed (654_CR1) 2014; 127 J-J Pang (654_CR37) 2011; 52 JD Rohrer (654_CR41) 2011; 134 AJ Barkovich (654_CR5) 2000; 21 GC Gilmore (654_CR15) 1995; 72 T Ochiishi (654_CR34) 1994; 634 S Yoneda (654_CR48) 2005; 49 M Bocchetta (654_CR6) 2015; 262 S Ourselin (654_CR36) 2000 E Miot-Noirault (654_CR29) 1997; 72 N Gupta (654_CR17) 2008; 43 K Rascovsky (654_CR40) 2011; 134 JD Warren (654_CR46) 2013; 347 A Velasco (654_CR45) 2008; 582 W-L Ho (654_CR19) 2012; 18 MF Mendez (654_CR28) 1996; 83 WL Ho (654_CR18) 2015; 124 M Modat (654_CR30) 2010; 98 N Sahara (654_CR42) 2014; 35 X Ou (654_CR35) 2009; 61 JA Wells (654_CR47) 2015; 111 L Csincsik (654_CR11) 2018; 59 A Cronin-Golomb (654_CR10) 1991; 29 N Mazzaro (654_CR27) 2016; 36 654_CR26 M Almasieh (654_CR3) 2012; 31 JR Hodges (654_CR20) 2004; 56 C Nucci (654_CR31) 2011; 39 J O’Callaghan (654_CR32) 2014; 9 M Chiasseu (654_CR8) 2016; 36 J Avila (654_CR4) 2006; 2006 H Seelaar (654_CR44) 2011; 82 D Ma (654_CR25) 2014; 9 DJ Calkins (654_CR7) 2005; 481 GR Jackson (654_CR21) 2003; 21 L Gasparini (654_CR14) 2011; 32 R Rademakers (654_CR39) 2004; 24 M Jorge Cardoso (654_CR22) 2013; 17 P Albrecht (654_CR2) 2012; 7 A Cronin-Golomb (654_CR9) 1995; 35 PA Yushkevich (654_CR49) 2006; 31 N Deters (654_CR12) 2008; 28 F Leger (654_CR24) 2011; 70 J O'Callaghan (654_CR33) 2017; 159 BJ Kim (654_CR23) 2017; 89 L Pérez De Sevilla Müller (654_CR38) 2007; 505 31383030 - Acta Neuropathol Commun. 2019 Aug 5;7(1):127 |
| References_xml | – volume: 36 start-page: 5785 issue: 21 year: 2016 ident: 654_CR8 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3986-15.2016 – volume: 59 start-page: 182 issue: 4 year: 2018 ident: 654_CR11 publication-title: Ophthalmic Res doi: 10.1159/000487053 – volume: 49 start-page: 106 issue: 2 year: 2005 ident: 654_CR48 publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-004-0156-x – volume: 21 start-page: 1099 issue: 6 year: 2000 ident: 654_CR5 publication-title: Am J Neuroradiol – ident: 654_CR26 doi: 10.3389/neuro.05.001.2008 – volume: 29 start-page: 41 issue: 1 year: 1991 ident: 654_CR10 publication-title: Ann Neurol doi: 10.1002/ana.410290110 – volume: 89 start-page: 1604 issue: 15 year: 2017 ident: 654_CR23 publication-title: Neurology doi: 10.1212/WNL.0000000000004500 – volume: 134 start-page: 2456 issue: 9 year: 2011 ident: 654_CR40 publication-title: Brain doi: 10.1093/brain/awr179 – volume: 21 start-page: 955 issue: 5 year: 1998 ident: 654_CR16 publication-title: Neuron doi: 10.1016/S0896-6273(00)80615-7 – volume: 347 start-page: f4827 year: 2013 ident: 654_CR46 publication-title: The BMJ doi: 10.1136/bmj.f4827 – volume: 36 start-page: 2086 issue: 7 year: 2016 ident: 654_CR27 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0774-15.2016 – volume: 111 start-page: 369 year: 2015 ident: 654_CR47 publication-title: NeuroImage doi: 10.1016/j.neuroimage.2015.02.023 – volume: 124 start-page: 16 year: 2015 ident: 654_CR18 publication-title: Life Sci doi: 10.1016/j.lfs.2014.12.019 – volume: 72 start-page: 83 issue: 2 year: 1995 ident: 654_CR15 publication-title: Optom Vis Sci doi: 10.1097/00006324-199502000-00007 – volume: 39 start-page: 279 issue: 3 year: 2011 ident: 654_CR31 publication-title: Clin Exp Ophthalmol doi: 10.1111/j.1442-9071.2010.02452.x – volume: 582 start-page: 901 issue: 6 year: 2008 ident: 654_CR45 publication-title: FEBS Lett doi: 10.1016/j.febslet.2008.02.025 – volume: 159 start-page: 334 year: 2017 ident: 654_CR33 publication-title: NeuroImage doi: 10.1016/j.neuroimage.2017.08.003 – volume: 35 start-page: 370 issue: 3 year: 1995 ident: 654_CR9 publication-title: The Gerontologist doi: 10.1093/geront/35.3.370 – volume: 98 start-page: 278 issue: 3 year: 2010 ident: 654_CR30 publication-title: Comput Methods Prog Biomed doi: 10.1016/j.cmpb.2009.09.002 – volume: 32 start-page: 419 issue: 3 year: 2011 ident: 654_CR14 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2009.03.002 – volume: 35 start-page: 1364 issue: 6 year: 2014 ident: 654_CR42 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2013.12.009 – volume: 505 start-page: 177 issue: 2 year: 2007 ident: 654_CR38 publication-title: J Comp Neurol doi: 10.1002/cne.21487 – volume: 2006 start-page: 74539 year: 2006 ident: 654_CR4 publication-title: J Biomed Biotechnol doi: 10.1155/JBB/2006/74539 – volume: 70 start-page: 63 issue: 1 year: 2011 ident: 654_CR24 publication-title: J Neuropathol Exp Neurol doi: 10.1097/NEN.0b013e31820376cc – volume: 309 start-page: 476 issue: 5733 year: 2005 ident: 654_CR43 publication-title: Science doi: 10.1126/science.1113694 – volume: 134 start-page: 2565 issue: 9 year: 2011 ident: 654_CR41 publication-title: Brain doi: 10.1093/brain/awr198 – volume: 82 start-page: 476 issue: 5 year: 2011 ident: 654_CR44 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2010.212225 – volume: 262 start-page: 2635 issue: 12 year: 2015 ident: 654_CR6 publication-title: J Neurol doi: 10.1007/s00415-015-7885-2 – volume: 28 start-page: 137 issue: 1 year: 2008 ident: 654_CR12 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2008.06318.x – volume: 21 start-page: 709 issue: 3 year: 2003 ident: 654_CR21 publication-title: Neurol Clin doi: 10.1016/S0733-8619(02)00107-X – volume: 481 start-page: 194 issue: 2 year: 2005 ident: 654_CR7 publication-title: J Comp Neurol doi: 10.1002/cne.20368 – volume: 83 start-page: 987 issue: 3 year: 1996 ident: 654_CR28 publication-title: Percept Mot Skills doi: 10.2466/pms.1996.83.3.987 – volume: 72 start-page: 5 issue: 1 year: 1997 ident: 654_CR29 publication-title: J Neurosci Methods doi: 10.1016/S0165-0270(96)00148-3 – volume: 31 start-page: 152 issue: 2 year: 2012 ident: 654_CR3 publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2011.11.002 – volume: 127 start-page: 667 issue: 5 year: 2014 ident: 654_CR1 publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1254-6 – volume: 56 start-page: 399 issue: 3 year: 2004 ident: 654_CR20 publication-title: Ann Neurol doi: 10.1002/ana.20203 – volume: 24 start-page: 277 issue: 4 year: 2004 ident: 654_CR39 publication-title: Hum Mutat doi: 10.1002/humu.20086 – volume: 61 start-page: 364 issue: 2 year: 2009 ident: 654_CR35 publication-title: Magn Reson Med doi: 10.1002/mrm.21850 – volume: 9 start-page: e96568 issue: 5 year: 2014 ident: 654_CR32 publication-title: PLOS ONE doi: 10.1371/journal.pone.0096568 – volume: 18 start-page: 2700 year: 2012 ident: 654_CR19 publication-title: Mol Vis – volume: 52 start-page: 4886 issue: 7 year: 2011 ident: 654_CR37 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.10-5921 – volume: 31 start-page: 1116 issue: 3 year: 2006 ident: 654_CR49 publication-title: NeuroImage doi: 10.1016/j.neuroimage.2006.01.015 – volume: 9 issue: 1 year: 2014 ident: 654_CR25 publication-title: PLoS One doi: 10.1371/journal.pone.0086576 – volume: 7 issue: 4 year: 2012 ident: 654_CR2 publication-title: PLoS One doi: 10.1371/journal.pone.0034891 – volume: 43 start-page: 53 issue: 1 year: 2008 ident: 654_CR17 publication-title: Can J Ophthalmol doi: 10.3129/i07-185 – volume: 56 start-page: 1101 issue: 3 year: 2017 ident: 654_CR13 publication-title: J Alzheimers Dis doi: 10.3233/JAD-160886 – volume: 17 start-page: 671 issue: 6 year: 2013 ident: 654_CR22 publication-title: Med Image Anal doi: 10.1016/j.media.2013.02.006 – start-page: 557 volume-title: Medical Image Computing and Computer-Assisted Intervention – MICCAI 2000: Third International Conference, Pittsburgh, PA, USA, October 11–14, 2000. Proceedings year: 2000 ident: 654_CR36 doi: 10.1007/978-3-540-40899-4_57 – volume: 634 start-page: 257 issue: 2 year: 1994 ident: 654_CR34 publication-title: Brain Res doi: 10.1016/0006-8993(94)91928-3 – reference: 31383030 - Acta Neuropathol Commun. 2019 Aug 5;7(1):127 |
| SSID | ssj0000911388 |
| Score | 2.2194164 |
| Snippet | Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have been... Abstract Visual impairments, such as difficulties in reading and finding objects, perceiving depth and structure from motion, and impaired stereopsis, have... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 4 |
| SubjectTerms | Animals Disease Models, Animal Female Frontotemporal dementia Frontotemporal Dementia - complications Frontotemporal Dementia - genetics Frontotemporal Dementia - pathology Humans Kinases Male Mice, Transgenic Middle Aged MRI Mutation Neurosensory retina Optic Nerve - pathology Pathology Retina Retinal Degeneration - complications Retinal Degeneration - genetics Retinal Degeneration - pathology Retinal Ganglion Cells - pathology Tau tau Proteins - genetics |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxRBEG4kB_Eivp0kaguCIAyZ6XcfoxiCEL0kkFvTr0kWZDZs1oP_PlU9nWEHQS8edg_b1UtPPbqrpqu-IuSD9iBVpkyLBT0QoETZghV1bWRcJuaTjhLrnc--q9ML8e1SXu60-sKcsAkeeGLcEeuzifAVE9cQykF0wEISOYbOp5hycY3gzNsJpsoeDDbMjanXmL1RR7cCcWggcoaPkqJVi4Oo4PX_uSvvHEvLlMmdM-jkCXlcnUd6PC36KXmQx2fk4Vm9Hn9Obn7ABhDpiFmMdHu9Ku2IqB8TnWArIWRdb35TLFzE_0n5qoBOo2zoaoQZmW7OrwQYEMU3ApmWPjl0PdCh4BxUHCucWbKM_AtycfL1_MtpW1sqtFHaftuGzHniMohgA0_oTHTRCi2HTkQD8hwY8zwPRoqEOwHvs9DKD0PokrUxe_6S7I3rMb8mlCkerep7DUwRYUi2j1llkxN4lDwOtiHdPX9drHjj2Pbipytxh1FuEokDkTgUiVMN-TRPuZnANv5G_BmFNhMiTnb5AbTHVe1x_9KehrxDkbup6HS2dncsldEYy5mGfCwUaO-w_Ohr2QIwAZGzFpSHC0qw07gcvlcrV_eJW1ifMkJI1rGGvJ-HcSbmvo0ZZI004KZCGCga8mrSwvmhIeDrMUu5IXqhnwuuLEfG1XVBEVd4x2bF_v9g4wF5BI6kLa-m9CHZ225-5TfgrG3D22KXd2QgPmI priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA9aQXwRv12tGkEQhKW7m-8nqWIpQvWlhXsL2SR7PSi759350P--M9nc2kXow93DZXLsZjKTmcnMbwj5pBxwtZG6xIIecFC8KEGKqtI3TITGBeUF1juf_ZKnF_znQixywG2b0yr3OjEp6jB4jJEfNbXUnAvw1b-u_5TYNQpvV3MLjfvkAUKXYUqXWqgpxgJnYc20zpeZtZZHW45oNOA_w0cKXsrZcZRQ-__XzbcOp3ni5K2T6OQJeZxNSHo88vwpuRf7Z-ThWb4kf07Wv0ENeNpjLiPdXa5SUyLq-kBH8EpwXIfNNcXyRfyfEJcJeho5RFc9zIh0c77kIEYU4wKRpm45dOhol9AOMpoVzky5Ru4FuTj5cf79tMyNFUovTL0r28hYYKLlrWlZQJOi8oYr0VXca-Bq1zSOxU4LHlAfsDpyJV3XtVUwxkfHXpKDfujja0IbybyRda1gUXjbBVP7KKOOAexK5jtTkGq_vtZn1HFsfnFlk_ehpR1ZYoElFlliZUG-TFPWI-TGXcTfkGkTIaJlpx-GzdJm4bNNHbWHLx-Y4hJMYt20gUffVi74EF1BPiDL7Vh6Osm8PRZSK_TodEE-JwqUenh873LxAiwC4mfNKA9nlCCtfj6831Y2a4ut_be3C_JxGsaZmAHXR-A10oCxCs4gL8ircRdOLw1uX425ygVRs_05W5X5SL-6TFjiEm_aDH9z92O9JY_AUDQp9KQOycFu8ze-A2Ns175PEncDPJA0Pw priority: 102 providerName: ProQuest |
| Title | Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30616676 https://www.proquest.com/docview/2168445202 https://www.proquest.com/docview/2165058264 https://pubmed.ncbi.nlm.nih.gov/PMC6322294 https://doaj.org/article/21e8c21ecd374699982bd4ecb0adcdea |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Za9tAEB5yQOlL6R2lqbuFQqGgVtpTeiglKQmh4LSUGPy2SLsrxxDk1HGg-fedWckmoiEP8oN2Vqzn2pk9vgH4YCqUKtdFShd6MEFxKkUrylLHhfK88sYpuu88PtOnE_ljqqZbsC5v1TPw-t7UjupJTZaXn__-uf2GBv81Gnyhv1xLgpjBpBgfrWSqt2EXJyZDdjruo_3omNGwRaxEyVEVU4XBe7_Pee9XBjNVBPT_323fmbeGZyrvTFInT-FJH12yw04dnsFWaJ_Do3G_f_4Crn6ih3CspWOObHUxj_WKWNV61uFaYk67WN4yutlI3_FhFlGpSXhs3mKPwJbnM4kWxmjJILBYSIctGtZEIIQe6Ip6xmNI1UuYnByffz9N-5oLqVNlvkrrIIQXqpZ1WQtP0UbmSmlUk0lXoMAbzisRmkJJT65C5EEaXTVNnfmydKESr2CnXbRhDxjXwpU6zw0yRdaNL3MXdCiCx5BTuKZMIFvz17oekJzqYlzamJgU2nYisSgSSyKxOoFPmy5XHRrHQ8RHJLQNIQFpxxeL5cz2dml5HgqHP84LIzVGywWvvQyuzirvfKgSeEcit92t1I07sIdKF4aSvSKBj5GCVBSH76r-XgMygaC1BpQHA0o0ZDdsXquVXdsBjk8XUiqe8QTeb5qpJx2OawPKmmgwjsU8USbwutPCzZ_GjDCnY8wJmIF-DrgybGnnFxFmXNMmXCn3Hx71G3iMMWQZV6XMAeysljfhLcZpq3oE22ZqRrB7dHz26_cornaMokX-Aye1PGY |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1Na9RA9FG3oF7Eb6PVjqAIQmiSmUwmB5FWW7a2u4q00Ns0mZlsFyS77q5I_5S_0fcm2dgg9NZDcsi8Ccm875n3AfAmKxCriVQhJfSgg2LSELkoCk3CU5sUNjMp5TuPxnJ4Kr6cpWcb8GedC0NhlWuZ6AW1nRnaI99JYqmESNFX_zj_GVLXKDpdXbfQaMjiyF3-Rpdt-eHwM-L3bZIc7J98GoZtV4HQpHm8CkvHueVpKcq85Jb0aWRykaVVJIzCX6qSpOCuUqmwxAw8diKTRVWVkc1z4wqO770Fm4KjKzOAzb398bfv3a4Oat-YK9Uen8ZK7iwF1b9Bjx0vmYpQ9hSg7xPwvza4og77oZpXdN_BfbjXGq1st6GyB7Dh6odwe9Qeyz-C-VcUPIbVFD3JVhdT3waJFbVlTblMdJVni0tGCZP0Husmvtg10QSb1jjDscXJRCDjMtqJcMz352GzilW-vkJbP4tm-uim4jGc3siiP4FBPavdM2CJ5CaXcZzhooiysnlsnHTKWbRkuanyAKL1-mrT1jmndhs_tPd3lNQNSjSiRBNKtAzgfTdl3hT5uA54j5DWAVJ9bv9gtpjolt11Ejtl8GYsz4REI1wlpRXOlFFhjXVFANuEct0ku3ZSRu-mUmXkQ6oA3nkIkjP4-aZo0yVwEahiVw9yqweJ8sH0h9dkpVv5tNT_uCmA190wzaSYu9ohrgkGzWN0P0UATxsq7H4aHc2YoqMDyHr02VuV_kg9vfDVyyWd7eXi-fWftQ13hiejY318OD56AXfRTM39xle2BYPV4pd7iabgqnzV8h-D85tm-b_SJ3Na |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optic+nerve+thinning+and+neurosensory+retinal+degeneration+in+the+rTg4510+mouse+model+of+frontotemporal+dementia&rft.jtitle=Acta+neuropathologica+communications&rft.au=Harrison%2C+Ian+F&rft.au=Whitaker%2C+Rozalind&rft.au=Bertelli%2C+Pietro+Maria&rft.au=O%27Callaghan%2C+James+M&rft.date=2019-01-07&rft.pub=BioMed+Central+Ltd&rft.issn=2051-5960&rft.eissn=2051-5960&rft.volume=7&rft.issue=1&rft_id=info:doi/10.1186%2Fs40478-018-0654-6&rft.externalDocID=A568748758 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2051-5960&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2051-5960&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2051-5960&client=summon |